HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.

AbstractPURPOSE:
A minority of children with Wilms tumor will experience tumor recurrence. In a previous pilot study we found an association between expression of an immune costimulatory molecule, B7-H1, and tumor recurrence in favorable histology Wilms tumor. We sought to verify the prognostic value of B7-H1 as a biomarker in favorable histology Wilms tumor.
MATERIALS AND METHODS:
We performed a nested case-control study of tumors from the Fifth National Wilms Tumor Study. We randomly selected 44 children unsuccessfully treated (cases) and 49 who were successfully treated for favorable histology Wilms tumor (controls). Cases and controls were matched based on tumor stage, and the analysis was restricted to children who underwent initial resection. We excluded patients with stage IV or V disease and those treated with chemotherapy or radiation. Tumor specimens were stained for B7-H1 expression.
RESULTS:
Of the 93 total samples analyzed 60 (65%) demonstrated B7-H1 staining, with staining diffusely present in 13 (22%) and blastema predominant in 34 (57%). B7-H1 expression was associated with failure of initial therapy (p = 0.006). Patients with tumors showing less than 20% B7-H1 positive cells were at lower risk for treatment failure, while those with tumors exhibiting greater than 60% B7-H1 positive cells were at greater risk for treatment failure. This association appeared to be independent of tumor stage.
CONCLUSIONS:
B7-H1 expression by favorable histology Wilms tumor is associated with an increased risk of failure of initial therapy.
AuthorsJonathan C Routh, Paul E Grundy, James R Anderson, Alan B Retik, Kyle C Kurek
JournalThe Journal of urology (J Urol) Vol. 189 Issue 4 Pg. 1487-92 (Apr 2013) ISSN: 1527-3792 [Electronic] United States
PMID23154206 (Publication Type: Journal Article)
CopyrightCopyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Chemical References
  • B7-H1 Antigen
  • Biomarkers
Topics
  • Adolescent
  • B7-H1 Antigen (analysis, biosynthesis)
  • Biomarkers (analysis)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Kidney Neoplasms (chemistry, epidemiology, metabolism, pathology, therapy)
  • Male
  • Neoplasm Recurrence, Local (epidemiology)
  • Prognosis
  • Risk
  • Treatment Failure
  • Wilms Tumor (chemistry, epidemiology, metabolism, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: